What is the current landscape of cancer drug development?
The landscape of cancer drug development has evolved significantly in recent years. With advancements in molecular biology, genomics, and biotechnology, researchers have gained a deeper understanding of cancer biology. This has led to the development of targeted therapies, immunotherapies, and personalized medicine approaches. The approval of drugs such as immune checkpoint inhibitors and CAR-T cell therapy exemplifies the shift towards more precise and effective treatments.
